Objective: to determine whether medication use patterns in community-dwelling elderly people vary with level of cognitive function-dementia, cognitive impairment (but not dementia) and intact cognition. Design: cross-sectional survey. Setting: a five-county area of central North Carolina, USA. Participants: 520 members of the Duke Established Populations for Epidemiologic Studies of the Elderly. Measurements: medication use in the previous 2 weeks was ascertained during a interview in the patient's home and was coded as to prescription and therapeutic class status. Cognitive status, the primary independent variable, was divided into: (i) dementia (n = 100); (ii) cognitive impairment but not dementia (n = 117); and (iii) cognitively intact (n = 303). The dependent variables were any prescription or over-the-counter (OTC) medication use (liS nonuse); number of prescription or OTC medications used; and prescription and OTC use combined within major therapeutic classes. Multivariate analyses controlled for socio-demographic characteristics, health status, functional status and access to health care. Results: the use of any prescription medication was similar in the three groups. The demented were significantly less likely than cognitively impaired people to use any OTC medications (OR = 0.65, 95% CI = 0.45, 0.93), cardiovascular medications (OR = 0.70,95% CI = 0.49,0.99) and analgesiCS (OR = 0.54,95% CI = 0.39,0.75). As a combined group, those who were demented and cognitively impaired were less likely than the cognitively intact group to use any OTC medications (OR = 0.78, 95% CI 0.65, 0.92). Compared with the cognitively impaired subjects, the demented group took fewer prescription medications ((3 coefficient = -0.31, 95% CI = -0.59, -0.03) and similar numbers of OTC medications. Compared with those who were cognitively intact, the combined group of demented and cognitively impaired subjects took fewer OTC medications ((3 coefficient = -0.14, 95% CI = -0.23, -0.05) and similar numbers of prescription medications. Conclusion: increasing level of cognitive dysfunction is associated with decreased use of OTe, cardiovascular and analgesic medications and the use of fewer prescription medications. These results suggest important differences in medication use patterns among community-dwelling elderly people who vary in cognitive status.
Introduction
Investigation of medication use patterns in a population (or pharmaco-epidemiology) is useful for describing variations in medication use and potentially detecting overuse or underuse of medications [1] . Pharmaco-epidemiological studies are important in elderly community residents with dementia or cognitive impairment because these conditions may be risk factors for over-and under-medication as well as for non-compliance and adverse drug reactions [2 -4] . In addition, pharmaco-epidemiological studies can determine whether medications increase or decrease the risk of a given condition [1] . This is important in dementia or cognitive impairment because medications may cause or exacerbate these conditions and medications are among the most common causes of reversible confusional states in elderly people [5 -7] . In addition, recent pharmaco-epidemiological studies have suggested that certain medications, such as antiinflammatory agents, may be protective against dementia or cognitive impairment [8 -11] . These phenomena can affect many elders given that estimates of the prevalence of dementia and cognitive impairment in persons over 65 years old are as high as 10% and 20%, respectively [12] .
However, few investigators have studied medication use patterns in demented or cognitively impaired community-dwelling elderly people. The few studies of medication use in demented subjects define dementia by clinical criteria and typically focus on Alzheimer's disease. In these studies, Alzheimer's disease patients averaged fewer medications per person and took more psychotropic medications than old people who were cognitively intact [13] [14] [15] . Studies of medication use in cognitively impaired people identify cognitive impairment in terms of scores below standardized cut-points on cognitive screening tests. We reported that cognitively impaired elderly subjects were significantly less likely to use any prescription or non-prescription (or over-the-counter; OTC), medications than cognitively intact older people in the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) [16] .
No studies have reported on medication use patterns across different levels of cognitive function (i.e. dementia, cognitive impairment but not dementia and intact cognition) within a given population. In the present study we distinguished dementia from cognitive impairment and intact cognition in a subsample of Duke EPESE participants to examine medication use in these groups. The objective of the study was to determine whether patterns of medication use among communitydwelling older people vary with level of cognitive function.
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Methods
Participants
The participants were selected sample members of the Duke EPESE [17, 18] who participated in a separate study of the incidence and prevalence of dementia in North Carolina, USA. The Duke EPESE conducted a baseline face-to-face interview in 1986-87 (n = 4162) and a second follow-up face-to-face interview in 1989-90 among the remaining participants (n = 3337). The independent dementia study was conducted after the second interview between 1991 and 1994. The dementia study participants were selected by the following criteria: (i) a two-point or greater decline between the first and second interview on the Short Portable Mental Status Questionnaire, a 10-item standardized cognitive screening instrument [19] or (ii) the need for a proxy respondent at the second interview but not the baseline interview. A 10% random sample of the remaining participants was also included. The selection procedure was intended to maximize the presence of persons with cognitive impairment and dementia and to identify a sample of persons who were cognitively intact.
Ofthe 3337 sample members of Duke EPESE seen in 1989-90, 547 met the selection criteria. Twenty-seven participants were excluded because they no longer lived in the interviewing catchment area, were too physically ill to participate, were acutely disoriented or refused. The current analysis is therefore based on 520 participants.
Data collection
Data for this study came from the Duke EPESE and the dementia study. The Duke EPESE provided data on age, race, sex and years of education [17] . The dementia study obtained separate data on current marital status, medication use, cognition, basic activities of daily living, eight common chronic health conditions, hospitalizations in the previous year and whether the participant had a regular primary-care phYSician. The dementia study interviewers administered a structured questionnaire in the home to participants or informants, typically a close family member, to obtain the information.
The dementia study interviewers asked participants or informants to show them all prescription and OTC medications taken in the past 2 weeks. OTC drugs are medications that can be purchased without a prescription or doctor's orders (e.g. laxatives, analgesics). The name and dosage form of each medication taken in the previous 2 weeks were recorded from the container. A trained pharmacy technician assigned each medication a unique four-digit generic code from the DPICS and INDPICS coding system [20] using a locally developed interactive data-entry program [21] . The program numerically coded each medication to indicate whether it was a prescription or OTC product and assigned the medications to non-overlapping therapeutic medication classes based on American Hospital Formulary Service Drug Information [22] .
The dementia study interviewers administered the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychology battery to participants [23] . This test battery includes the Mini-Mental State Examination (MMSE) [24] , a lO-item word list learning, recall and recognition task, a measure of verbal fluency, confrontation naming (abbreviated 15-item Boston naming test) and a constructional praxis task. The clock drawing test, which is part of the CERAD clinical battery [23] was also included. Additional information on memory, ability to perform activities of daily living and change in personality was obtained from an informant.
The following criteria were used to refer a participant for a clinical dementia evaluation: a participant or informant report of memory problems, an inadequate clock drawing, an MMSE score less than 24 for whites [24] and less than 18 for blacks [25] ' a recall of three items or less from the word list learning task [26] or the interviewer's assessment that dementia was potentially present. These criteria were designed to be broadly inclusive of potential dementia.
Determination of cognitive status
Dementia
Based on the above criteria, 183 of the 520 study participants were recommended for a clinical evaluation for dementia. A geriatrician or specially trained clinical research nurse performed the dementia evaluation using the CERAD clinical battery, which was designed to assess Alzheimer's disease and expanded to include non-Alzheimer's disease dementias [23] . A neurologist, geriatrician and clinical research nurse diagnosed dementia and its aetiology in 100 of the 183 participants by clinical consensus using CERAD, Diagnostic and Statistical Manual of Mental Disorders-IV and modified National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association criteria for dementia and Alzheimer's disease [23, 27, 28] . Of the demented subjects, 69 had Alzheimer's disease, either alone or with additional components, 15 had vascular dementia, in some cases with additional factors but excluding Alzheimer's disease, while 16 had other forms of dementia.
Cognitive impairment
Cognitive impairment, defined as abnormal responses to cognitive testing in persons without dementia, was Cognitive function and medication use patterns ascertained in the remaining 420 participants using the MMSE. The originally recommended and commonly accepted clinical cut-off point on the MMSE for identifying cognitive impairment is 23/24 [24] . In order not to include cognitively intact elderly people with little education in the cognitively impaired sample, we modified these cut-off points to reflect the population-based age and education norms published by Crum et at. [29] . Once age and education have been taken into account, the effect of race, while important, is rarely substantive [25, [29] [30] [31] .
Since the median age for the participants fell between the age categories of 75-79 and 80-84, we pro-rated the cut-off point identifying the 25th percentile for these two age groups, separately for those with 0-4 (cut-off point 17/18) and 5-8 years of schooling (cut-off point 22/23). We selected the 25th percentile rather than a cut-off point based on the mean and standard deviation because the scores on the MMSE are not normally distributed. Using these cut-off points, 117 participants were identified as cognitively impaired. These cognitively impaired participants did not meet criteria for dementia at the time of the study and constituted a group separate from the groups with dementia or intact cognition.
Cognitively intact
This was defined as no evidence for dementia or cognitive impairment after clinical examination or having an MMSE score above the indicated cut-off points. Using this definition, 303 participants were cognitively intact.
Dependent variables
We were interested in the presence and extent of prescription and OTC medication use and had three types of dependent variables. First, we considered any use of prescription medications versus no use and any use of OTe medications versus no use. Second, we examined the number of prescription or OTC medications used. Thirdly, we examined prescription and OTe use combined within major therapeutic classes.
Independent variables
The primary independent variable was cognitive status (dementia, cognitively impaired but not demented and cognitively intact). As covariates, we selected variables that may be associated with medication use behaviour or possible confounders in order to control for them in the analysis. The demographic variables were age (years), race (black, white), sex, education (years of schooling) and marital status (married, not married). Physical functioning status was assessed by ability to independently perform each of five activities of daily living: bathing, grooming, dressing, transfer from bed to chair and feeding oneself [32, 33] . Subjects who were unable to perform one or more items independently were compared with those who could perform all items. Health status was assessed by the reported presence of each of eight common chronic health conditions (arthritis, cancer, diabetes, heart disease, hypertension, stroke, thyroid dysfunction and pulmonary disorder) and by the total number of these conditions present. Health service use was assessed by two variables: hospitalization overnight in the previous year and whether the participant had a regular primary-care physician.
Statistical analysis
Descriptive statistics were used for initial comparison of the cognitively intact, cognitively impaired and demented. For univariate analyses, the X 2 test was used for categorical variables and analysis of variance (ANOVA) was used for continuous variables [34] . The assumption of normality for ANOVA was examined. For multivariate analyses, logistic regression was used when the dependent variable was dichotomous (any medication use versus non-use). Ordinary least-squares regression was used when the dependent variable was continuous (number of medications used) [35] .
The multivariate regression models included the covariates and two indicator variables that reflected cognitive status. The indicator variables were calculated by orthogonal contrasts. The first indicator contrasted a combined group of cognitively impaired and demented participants with the group of cognitively intact participants. The second variable contrasted the cognitively impaired with the demented participants. These two variables permit all comparisons among the three groups to be examined. All of the analyses were conducted using SAS software [36] .
Results
Participant characteristics by cognitive status are presented in Table 1 . There were significant mean age differences between the three groups. The demented group were, on average, the oldest (83 years) followed by the cognitively impaired (80 years) and cognitively intact (77 years) groups. The cognitively impaired subjects were the most likely (73.5%) and the cognitive intact were the least likely (52.8%) to be black. Mean level of education differed significantly, the demented population having on average the least education (6.7 years) and the cognitively intact the most education (8.8 years). Marital status followed a similar pattern, with those who were demented least likely to be married 07%) and those who were cognitively intact the most likely to be married (38%). With respect to health-related information, a significantly higher proportion of the demented subjects had impairments in functional status. No significant differences were identified in the mean number of chronic conditions or in diseases, with the exception of stroke (reported in a larger proportion of the demented) and arthritis (reported in a smaller proportion of the demented). There were no significant differences in hospitalization but registration with a regular doctor was significantly less frequent in the demented group than for members of the other two groups. Table 2 provides information on medication use. Although the mean number of prescription medications used was less in the demented group and a smaller percentage of this group used any OTC medications, the unadjusted analyses showed no statistically significant differences between the three groups in use of prescription, OTC or any medication. Overall, the proportion of participants using any medication ranged from 87 to 93% and mean number of medications used ranged from 3.4 to 3.8. Table 3 shows the association between level of cognitive function and prescription medication use, adjusting for other factors. There were no significant differences among the demented, cognitively impaired and cognitively intact groups in the relative odds of using any prescription medications. However, the demented group took significantly fewer prescription medications than the cognitively impaired group. Table 4 shows the adjusted associations between level of cognitive function and OTC medication use. There were significant differences among the three groups in the relative odds of using any OTC medications, with those who were demented or cognitively impaired less likely to be taking such products than the cognitively intact group, and the demented group less likely to do so than the cognitively impaired group. The combined group of demented and cognitively impaired took significantly fewer OTC medications than the cognitively intact group. Table 5 shows the association between use of medications by level of cognitive function and the most common therapeutic classes taken by the study participants. The demented people took fewer cardiovascular or analgesic medications but more central nervous system medications than either cognitively impaired or cognitively intact people. The use of these three therapeutic classes was examined in multivariate analyses (Table 6 ). Overall, the comhined group of demented and cognitively impaired people did not differ from the cognitively intact group in use of cardiovascular medications, analgesic medications or central nervous system agents, but the demented subjects were less likely to be taking either cardiovascular or analgesic medications.
Discussion
In this racially mixed sample of community-dwelling elderly people in North Carolina, the proportion of demented subjects using medications (87%) and the average number of medications per person (3.4) were substantial. This level of use was higher than that reported previously for patients with dementia or Alzheimer's disease [13] [14] [15] . When the demented group were differentiated from the cognitively impaired, demented people took significantly fewer prescription medications than those who were cognitively impaired. There are several possible explanations for the use of fewer prescription medications by subjects with dementia. People with dementia may not report treatable conditions, or those conditions may go unrecognized by clinicians or family members. Some dementia patients may be resistant to taking medications or more prone to adverse drug effects. For whatever reason, they may not see a physician regularly-an explanation supported by the significantly higher proportion of dementia patients who did not have a regular primary-care physician in this study.
In terms of OTC medication use, those with dementia were Significantly less likely to take any OTC medications and took fewer OTC medications than those who were cognitively impaired but not demented. Dementia may prevent patients from performing the functional and cognitive tasks necessary to obtain OTC medications, or they may have fewer conditions that are amenable to OTC medications. Alternatively, caregivers may not be aware of conditions treatable by OTC medications in these patients or may be concerned about their adverse effects. However, the underlying reason for this could not be ascertained from the study data.
Consistent with previous studies, we found the most frequently used therapeutic classes of medications in demented people were, in rank order: cardiovascular, analgesic, gastrointestinal, nutritional and central nervous system [13, 15) . Multivariate analysis revealed that demented people were significantly less likely than the cognitively impaired to be taking analgesics or . cardiovascular medications. The analgesic result was the most striking and concurs with previous studies [14] [15] [16] . It is possible that dementia patients may underreport pain or express pain in atypical ways and/or clinicians may undertreat pain in dementia [37) . Another interpretation is that demented participants (the majority of whom had Alzheimer's disease) were less likely to have arthritis, a leading indication for analgesic medications [10) . Alternatively, the higher use of analgesics by those who were not demented may represent a protective etIect of certain diseases or the medications used to treat them. This explanation is consistent with a growing literature on the protective effect of anti-inflammatory medications on the development of Alzheimer's disease and also with a lower than expected prevalence of Alzheimer's disease in patients with rheumatoid arthritis [9] [10] [11] .
It is important to recognize potential limitations of the study. The cross-sectional study design precluded any conclusions about causality, making it impossible to tell whether dementia or cognitive impairment caused or was the result of differences in medication use among the groups. Also, medications were categorized into broad therapeutic classes which did not allow for examination of individual medications for specific indications. Misclassification of cases of dementia or cognitive impairment is a potential concern but the study employed well-established, reliable, valid criteria to differentiate the groups [24, 27 -29) . Some of the cognitively impaired participants may have underlying pathology that will eventually lead to a diagnosis of dementia and theretore represent graded impairment between the groups. However, at the time of the study they did not meet standardized criteria for dementia. The selection process from the EPESE sample resulted in 520 partiCipants, which may have limited our statistical power to detect significant differences in the use of medications among the three groups where none was found. Finally, a study of community-dwelling elders living in the south-eastern USA may not be representative of other populations which may have different patterns of medication prescribing and OTC medication use.
In conclusion, findings from this study suggest that demented community-dwelling elderly people are less likely to be users of OTC, analgesic and cardiovascular medication than those who are cognitively impaired but not demented or those who are cognitively intact. Future research is needed to examine longitudinal medication use patterns and the use of specific medication classes for specific diseases in larger samples. Such research will be useful to confirm these results and, if they are confirmed, to determine the appropriateness of this variation in medication use patterns.
Key points
• In a study of older people of different races at home in the south-eastern USA, there is an average use of 3.4 medications per person.
• Demented subjects are less likely to use over-thecounter medications, analgesics or cardiovascular drugs.
